HCL001 Cell Injection

HCL001 · Shanghai Huicun Medical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HCL001 Cell Injection, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: HCL001 Cell Injection for Decompensated Cirrhosis: A Phase I/II Trial [Phase 1, Phase 2]